You are here

  • Home
  • Archive
  • Volume 8, Issue 1
  • Oncolytic adenovirus shapes the ovarian tumor microenvironment for potent tumor-infiltrating lymphocyte tumor reactivity

Article info

Article menu

Download PDFPDF

XML
Clinical/translational cancer immunotherapy
Original research
Oncolytic adenovirus shapes the ovarian tumor microenvironment for potent tumor-infiltrating lymphocyte tumor reactivity

Authors

  • João Manuel Santos Cancer Gene Therapy Group, Translational Immunology Research Program, Faculty of Medicine, University of Helsinki, Helsinki, Finland TILT Biotherapeutics, Helsinki, Finland PubMed articlesGoogle scholar articles
  • Camilla Heiniö Cancer Gene Therapy Group, Translational Immunology Research Program, Faculty of Medicine, University of Helsinki, Helsinki, Finland PubMed articlesGoogle scholar articles
  • Victor Cervera-Carrascon Cancer Gene Therapy Group, Translational Immunology Research Program, Faculty of Medicine, University of Helsinki, Helsinki, Finland TILT Biotherapeutics, Helsinki, Finland PubMed articlesGoogle scholar articles
  • Dafne C A Quixabeira Cancer Gene Therapy Group, Translational Immunology Research Program, Faculty of Medicine, University of Helsinki, Helsinki, Finland PubMed articlesGoogle scholar articles
  • Mikko Siurala Cancer Gene Therapy Group, Translational Immunology Research Program, Faculty of Medicine, University of Helsinki, Helsinki, Finland TILT Biotherapeutics, Helsinki, Finland PubMed articlesGoogle scholar articles
  • Riikka Havunen Cancer Gene Therapy Group, Translational Immunology Research Program, Faculty of Medicine, University of Helsinki, Helsinki, Finland TILT Biotherapeutics, Helsinki, Finland PubMed articlesGoogle scholar articles
  • Ralf Butzow Helsinki University Hospital Comprehensive Cancer Center, Helsinki, Finland PubMed articlesGoogle scholar articles
  • Sadia Zafar Cancer Gene Therapy Group, Translational Immunology Research Program, Faculty of Medicine, University of Helsinki, Helsinki, Finland PubMed articlesGoogle scholar articles
  • Tanja de Gruijl Cancer Center Amsterdam, Departments of Medical Oncology and Radiation Oncology, University Medical Center Amsterdam, Amsterdam, The Netherlands PubMed articlesGoogle scholar articles
  • Heini Lassus Department of Obstetrics and Gynecology, Helsinki University Hospital, Helsinki, Finland PubMed articlesGoogle scholar articles
  • Anna Kanerva Cancer Gene Therapy Group, Translational Immunology Research Program, Faculty of Medicine, University of Helsinki, Helsinki, Finland Department of Obstetrics and Gynecology, Helsinki University Hospital, Helsinki, Finland PubMed articlesGoogle scholar articles
  • Akseli Hemminki Cancer Gene Therapy Group, Translational Immunology Research Program, Faculty of Medicine, University of Helsinki, Helsinki, Finland TILT Biotherapeutics, Helsinki, Finland PubMed articlesGoogle scholar articles

Citation

Santos JM, Heiniö C, Cervera-Carrascon V, et al
Oncolytic adenovirus shapes the ovarian tumor microenvironment for potent tumor-infiltrating lymphocyte tumor reactivity
Journal for ImmunoTherapy of Cancer 2020;8:e000188. doi: 10.1136/jitc-2019-000188
Online issue publication 
January 11, 2022

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

© Author(s) (or their employer(s)) 2020. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. http://creativecommons.org/licenses/by-nc/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See http://creativecommons.org/licenses/by-nc/4.0/.